Pieris Pharmaceuticals
Why Robinhood?
You can watch PIRS and buy or sell other stocks, ETFs, and their options commission-free!About PIRS
Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas.
PIRS Key Statistics
Stock Snapshot
As of today, Pieris Pharmaceuticals(PIRS) shares are valued at $9.75. The company's market cap stands at 153.45M, with a P/E ratio of -1.08.
On 2026-06-10, Pieris Pharmaceuticals(PIRS) stock opened at —, reached a high of —, and a low of —.
Pieris Pharmaceuticals(PIRS) shares are trading with a volume of 0.
During the past year, Pieris Pharmaceuticals(PIRS) stock moved between $6.20 at its lowest and $18.68 at its peak.
During the past year, Pieris Pharmaceuticals(PIRS) stock moved between $6.20 at its lowest and $18.68 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.